93 related articles for article (PubMed ID: 8727701)
1. Flow cytometric DNA analysis of abnormal endometrium.
Sato S; Tanoguchi K; Tase T; Yajima A
Tohoku J Exp Med; 1996 Feb; 178(2):199-202. PubMed ID: 8727701
[TBL] [Abstract][Full Text] [Related]
2. L-type amino acid transporter 1 expression increases in well-differentiated but decreases in poorly differentiated endometrial endometrioid adenocarcinoma and shows an inverse correlation with p53 expression.
Watanabe J; Yokoyama Y; Futagami M; Mizunuma H; Yoshioka H; Washiya K; Hana K; Endou H; Okayasu I
Int J Gynecol Cancer; 2014 May; 24(4):659-63. PubMed ID: 24694899
[TBL] [Abstract][Full Text] [Related]
3. Influence of menopause on the cell kinetics of normal, hyperplastic, and malignant endometrium.
Ishihara H; Itamochi H
Gynecol Obstet Invest; 1995; 40(2):129-32. PubMed ID: 8575691
[TBL] [Abstract][Full Text] [Related]
4. DNA ploidy, cell cycle kinetics, and low versus high grade atypia in endometrial hyperplasia.
Michael H; Kotylo PK; Mohr M; Roth LM
Am J Clin Pathol; 1996 Jul; 106(1):22-8. PubMed ID: 8701927
[TBL] [Abstract][Full Text] [Related]
5. Telomerase expression in normal endometrium, endometrial hyperplasia, and endometrial adenocarcinoma.
Shroyer KR; Stephens JK; Silverberg SG; Markham N; Shroyer AL; Wilson ML; Enomoto T
Int J Gynecol Pathol; 1997 Jul; 16(3):225-32. PubMed ID: 9421087
[TBL] [Abstract][Full Text] [Related]
6. Flow cytometry of normal, hyperplastic, and malignant human endometrium. A study of ploidy and proliferative indices including comparison with in vitro S-phase labeling.
Thornton JG; Quirke P; Wells M
Am J Obstet Gynecol; 1989 Aug; 161(2):487-92. PubMed ID: 2475021
[TBL] [Abstract][Full Text] [Related]
7. Expression of nm23 in normal, hyperplastic and neoplastic endometrial tissues.
Brustmann H; Naudé S
Pathol Res Pract; 1999; 195(12):829-34. PubMed ID: 10631718
[TBL] [Abstract][Full Text] [Related]
8. [Expressions of aromatase protein and sex hormone receptor in endometrial lesions].
Ma XX; Zhang SL; Gao S; Lu JM; Dong F
Zhonghua Fu Chan Ke Za Zhi; 2006 Jun; 41(6):395-8. PubMed ID: 16831363
[TBL] [Abstract][Full Text] [Related]
9. Maspin expression, subcellular localization and clinicopathological correlation in endometrial hyperplasia and endometrial adenocarcinoma.
Blandamura S; Alessandrini L; Saccardi C; Giacomelli L; Fabris A; Borghero A; Litta P
Histol Histopathol; 2014 Jun; 29(6):777-83. PubMed ID: 24346847
[TBL] [Abstract][Full Text] [Related]
10. DNA ploidy, cell proliferation and steroid hormone receptors in endometrial hyperplasia and early adenocarcinoma.
Punnonen R; Mattila J; Kuoppala T; Koivula T
J Cancer Res Clin Oncol; 1993; 119(7):426-9. PubMed ID: 8491764
[TBL] [Abstract][Full Text] [Related]
11. Gain of OGP, an estrogen-regulated oviduct-specific glycoprotein, is associated with the development of endometrial hyperplasia and endometrial cancer.
Woo MM; Alkushi A; Verhage HG; Magliocco AM; Leung PC; Gilks CB; Auersperg N
Clin Cancer Res; 2004 Dec; 10(23):7958-64. PubMed ID: 15585630
[TBL] [Abstract][Full Text] [Related]
12. DNA ploidy and S-phase fraction analyses of hyperplastic, atypical and cancerous endometrium using flow cytometry from paraffin-embedded tissues.
Pervez S; Hitchcock A; Sinton TM; Mani A; Smith JL
Pathol Res Pract; 2002; 198(1):13-7. PubMed ID: 11866205
[TBL] [Abstract][Full Text] [Related]
13. Flow cytometric DNA analysis of normal and cancerous human endometrium and cytological-histopathological correlations.
Lindahl B; Alm P; Killander D; Långström E; Tropé C
Anticancer Res; 1987; 7(4B):781-9. PubMed ID: 3674763
[TBL] [Abstract][Full Text] [Related]
14. IMMUNOHISTOCHEMISTRY IN ENDOMETRIAL HYPERPLASIA AND ENDOMETRIAL ADENOCARCINOMA.
Socolov D; Socolov R; Lupascu IA; Rugina V; Gabia O; Garauleanu DM; Carauleanu A
Rev Med Chir Soc Med Nat Iasi; 2016; 120(2):355-62. PubMed ID: 27483717
[TBL] [Abstract][Full Text] [Related]
15. Heart and Neural Crest Derivatives Expressed Transcript 2 (HAND2): a novel biomarker for the identification of atypical hyperplasia and Type I endometrial carcinoma.
Buell-Gutbrod R; Cavallo A; Lee N; Montag A; Gwin K
Int J Gynecol Pathol; 2015 Jan; 34(1):65-73. PubMed ID: 25473755
[TBL] [Abstract][Full Text] [Related]
16. [Diagnosis of endometrial cancer by DNA cytophotometry].
Dietl J; Hedderich J; Sprenger E
Geburtshilfe Frauenheilkd; 1986 Nov; 46(11):796-9. PubMed ID: 3803873
[TBL] [Abstract][Full Text] [Related]
17. Expression of a putative stem cell marker Musashi-1 in endometrium.
Lu X; Lin F; Fang H; Yang X; Qin L
Histol Histopathol; 2011 Sep; 26(9):1127-33. PubMed ID: 21751144
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical analysis of CD44s and CD44v6 in endometriosis and adenomyosis : comparison with normal, hyperplastic, and malignant endometrium.
Lin Z; Cho S; Jeong H; Kim H; Kim I
J Korean Med Sci; 2001 Jun; 16(3):317-22. PubMed ID: 11410693
[TBL] [Abstract][Full Text] [Related]
19. Expression of receptor-binding cancer antigen expressed on SiSo cells and estrogen receptor subtypes in the normal, hyperplastic, and carcinomatous endometrium.
Zhou XH; Teng XD; Song WY; Wu YJ
Int J Gynecol Cancer; 2008; 18(1):152-8. PubMed ID: 17466050
[TBL] [Abstract][Full Text] [Related]
20. Correlation of proliferation indices, apoptosis, and related oncogene expression (bcl-2 and c-erbB-2) and p53 in proliferative, hyperplastic, and malignant endometrium.
Ioffe OB; Papadimitriou JC; Drachenberg CB
Hum Pathol; 1998 Oct; 29(10):1150-9. PubMed ID: 9781657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
